232 related articles for article (PubMed ID: 35684309)
1. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
Dragojevic S; Ryu JS; Hall ME; Raucher D
Molecules; 2022 May; 27(11):. PubMed ID: 35684309
[TBL] [Abstract][Full Text] [Related]
2. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
Walker L; Perkins E; Kratz F; Raucher D
Int J Pharm; 2012 Oct; 436(1-2):825-32. PubMed ID: 22850291
[TBL] [Abstract][Full Text] [Related]
3. Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.
Moktan S; Perkins E; Kratz F; Raucher D
Mol Cancer Ther; 2012 Jul; 11(7):1547-56. PubMed ID: 22532601
[TBL] [Abstract][Full Text] [Related]
4. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
Dragojevic S; Turner L; Raucher D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216417
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides.
Moktan S; Raucher D
Int J Pept Res Ther; 2012 Sep; 18(3):227-237. PubMed ID: 23105921
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Dragojevic S; Mackey R; Raucher D
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
[TBL] [Abstract][Full Text] [Related]
7. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.
Opačak-Bernardi T; Ryu JS; Raucher D
J Drug Target; 2017 Jul; 25(6):523-531. PubMed ID: 28140690
[TBL] [Abstract][Full Text] [Related]
8. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Bidwell GL; Fokt I; Priebe W; Raucher D
Biochem Pharmacol; 2007 Mar; 73(5):620-31. PubMed ID: 17161827
[TBL] [Abstract][Full Text] [Related]
9. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.
Kratz F; Ehling G; Kauffmann HM; Unger C
Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177
[TBL] [Abstract][Full Text] [Related]
10. Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin.
Liu L; Zhang C; Li Z; Wang C; Bi J; Yin S; Wang Q; Yu R; Liu Y; Su Z
Mol Pharm; 2017 Nov; 14(11):3739-3749. PubMed ID: 28950700
[TBL] [Abstract][Full Text] [Related]
11. Targeted drug delivery by thermally responsive polymers.
Chilkoti A; Dreher MR; Meyer DE; Raucher D
Adv Drug Deliv Rev; 2002 Sep; 54(5):613-30. PubMed ID: 12204595
[TBL] [Abstract][Full Text] [Related]
12. Elastin-Like Polypeptide Delivers a Notch Inhibitory Peptide to Inhibit Tumor Growth in Combination with Paclitaxel.
Ryu JS; Robinson L; Raucher D
J Chemother; 2019 Feb; 31(1):23-29. PubMed ID: 30773131
[TBL] [Abstract][Full Text] [Related]
13. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
Hearst SM; Walker LR; Shao Q; Lopez M; Raucher D; Vig PJ
Neuroscience; 2011 Dec; 197():369-80. PubMed ID: 21958864
[TBL] [Abstract][Full Text] [Related]
14. Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.
Ryu JS; Kratz F; Raucher D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498762
[TBL] [Abstract][Full Text] [Related]
15. The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage.
Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Kratz F; Walker UA
Int J Cancer; 2007 Feb; 120(4):927-34. PubMed ID: 17131338
[TBL] [Abstract][Full Text] [Related]
16. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.
Bidwell GL; Raucher D
Mol Cancer Ther; 2005 Jul; 4(7):1076-85. PubMed ID: 16020665
[TBL] [Abstract][Full Text] [Related]
17. Effects of Doxorubicin on the Liquid-Liquid Phase Change Properties of Elastin-Like Polypeptides.
Zai-Rose V; West SJ; Kramer WH; Bishop GR; Lewis EA; Correia JJ
Biophys J; 2018 Oct; 115(8):1431-1444. PubMed ID: 30292393
[TBL] [Abstract][Full Text] [Related]
18. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.
Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A
Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257
[TBL] [Abstract][Full Text] [Related]
20. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model.
Bidwell GL; Perkins E; Hughes J; Khan M; James JR; Raucher D
PLoS One; 2013; 8(1):e55104. PubMed ID: 23372821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
